Cellectis
Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates. The company is developing ALLO-715 and ALLO-605 for the treatment of multiple myeloma; ALLO-5...
Cellectis Logo
About Cellectis
Cellectis operates as a biopharmaceutical company. The Company develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. Cellectis serves patients and medical professionals worldwide.
Address
8, rue de la Croix Jarry,
Paris, 75013
France
Year founded
2000
Number of employees
200-300
Report inaccurate data
Request an update to help us keep the brand up-to-date.
